索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]李明艳,朱理敏.醛固酮增多症与阻塞性睡眠呼吸暂停低通气综合征的关系及治疗[J].国际心血管病杂志,2017,04:196-198,206.
点击复制

醛固酮增多症与阻塞性睡眠呼吸暂停低通气综合征的关系及治疗(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2017年04期
页码:
196-198,206
栏目:
综述
出版日期:
2017-07-25

文章信息/Info

Title:
-
作者:
李明艳; 朱理敏
200025 上海交通大学附属瑞金医院高血压科
Author(s):
-
关键词:
醛固酮增多症; 睡眠呼吸暂停综合征; 醛固酮
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2017.04.002
文献标识码:
-
摘要:
醛固酮增多症和阻塞性睡眠呼吸暂停低通气综合征(OSAHS)关系密切,可协同增加心血管病风险。醛固酮增多症患者OSAHS发病率升高,而OSAHS患者血浆醛固酮水平也明显升高。OSAHS可通过低氧血症兴奋交感神经系统和肾素-血管紧张素-醛固酮系统,促进醛固酮释放;OSAHS患者多合并肥胖,脂肪细胞及其衍生因子也可增加醛固酮的分泌。醛固酮增多症的水钠潴留增加夜间咽喉部水肿,加重OSAHS。对于合并醛固酮增多症的OSAHS患者,生活方式的改变、持续气道正压通气、盐皮质激素受体拮抗剂是有效的治疗方法。
Abstract:
-

参考文献/References

[1] 中国医师协会高血压专业委员会, 中华医学会呼吸病学分会睡眠呼吸障碍学组. 阻塞性睡眠呼吸暂停相关性高血压临床诊断和治疗专家共识[J]. 中国呼吸与危重监护杂志, 2013, 12(5):435-441.
[2] Somers VK, White DP, Amin R, et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing[J]. J Am Coll Cardiol, 2008, 52(8):686-717.
[3] Di Murro A, Petramala L, Cotesta D, et al. Renin-angiotensin-aldosterone system in patients with sleep apnoea: prevalence of primary aldosteronism[J]. J Renin Angiotensin Aldosterone Syst, 2010, 11(3):165-172.
[4] Funder JW, Carey RM, Mantero F, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab, 2016, 101(5):1889-1916.
[5] Jin ZN, Wei YX. Meta-analysis of effects of obstructive sleep apnea on the renin-angiotensin-aldosterone system[J]. J Geriatr Cardiol, 2016, 13(4):333-343.
[6] Barceló A, Piérola J, Esquinas C, et al. Relationship between aldosterone and the metabolic syndrome in patients with obstructive sleep apnea hypopnea syndrome: effect of continuous positive airway pressure treatment[J]. PLoS One, 2014, 9(1):e84362.
[7] Gonzaga CC, Gaddam KK, Ahmed MI, et al. Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension[J]. J Clin Sleep Med, 2010, 6(4):363-368.
[8] Muxfeldt ES, Margallo VS, Guimaraes GM, et al. Prevalence and associated factors of obstructive sleep apnea in patients with resistant hypertension[J]. Am J Hypertens, 2014, 27(8):1069-1078.
[9] Sim JJ, Yan EH, Liu IL, et al. Positive relationship of sleep apnea to hyperaldosteronism in an ethnically diverse population[J]. J Hypertens, 2011, 29(8):1553-1559.
[10] 杨丽睿, 孙 腾, 张慧敏, 等. 难治性高血压患者阻塞性睡眠呼吸暂停综合征与醛固酮水平的相关性[J]. 中华高血压杂志, 2013, 21(11):1028-1032.
[11] Born-Frontsberg E, Reincke M, Rump LC, et al. Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry[J]. J Clin Endocrinol Metab, 2009, 94(4):1125-1130.
[12] Prejbisz A, Florczak E, Klisiewicz AA, et al. Relationship between primary aldosteronism and obstructive sleep apnoea, metabolic abnormalities and cardiac structure in patients with resistant hypertension[J]. Endokrynol Pol, 2013, 64(5):363-367.
[13] Narkiewicz K, Somers VK. Sympathetic nerve activity in obstructive sleep apnoea[J]. Acta Physiol Scand, 2003, 177(3):385-390.
[14] 王广发. 阻塞性睡眠呼吸暂停低通气综合征的临床表现[J]. 中华结核和呼吸杂志, 2003, 26(5):262-263.
[15] Dinh Cat AN, Friederich-Persson M, White A, et al. Adipocytes, aldosterone and obesity-related hypertension[J]. J Mol Endocrinol, 2016, 57(1):F7-F21.
[16] Dudenbostel T, Calhoun DA. Resistant hypertension, obstructive sleep apnoea and aldosterone[J]. J Hum Hypertens, 2012, 26(5):281-287.
[17] Kasai T, Bradley TD, Friedman O, et al. Effect of intensified diuretic therapy on overnight rostral fluid shift and obstructive sleep apnoea in patients with uncontrolled hypertension[J]. J Hypertens, 2014, 32(3):673-680.

备注/Memo

备注/Memo:
基金项目:上海市卫生与计划生育委员会项目(20134109)
通信作者:朱理敏,Email:zhulimin@rjh.com.cn
更新日期/Last Update: 2017-07-25